BCM
DCPH

Burrage Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Burrage Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-59,818
Closed -$3.72M – 35
2019
Q4 		$3.72M Buy
+59,818
New +$2.84M 2.5% 16

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Burrage Capital Management's DCPH Position: Q1 2020 in Review

Burrage Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2020, closing a stake of 59,818 shares — an estimated $3.72M sold.

Burrage Capital Management first reported a position in DCPH in Q4 2019 and held it in 1 quarter. The position peaked at $3.72M in Q4 2019. 148 funds tracked by Wall St. Rank hold DCPH as of Q1 2020.

  • Burrage Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Burrage Capital Management sold 59,818 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $3.72M.
  • Burrage Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Burrage Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.72M in Q4 2019.
  • 148 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Burrage Capital Management's 13F filing for Q1 2020, filed 14 May 2020.